Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Can Aydogdu

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Annals of Surgical Oncology|February 10, 2026
ASO Practice Guidelines Series: Surgical Management of Bladder Cancer RelapseCan Aydogdu, Sean T McSweeney, Vignesh T Packiam, et al.
Annals of Surgical Oncology|June 21, 2026
Preoperative Tumor-Informed ctDNA for Prediction of Nodal Metastases at Radical Cystectomy in Bladder CancerCan Aydogdu, Betty Wang, Sean McSweeney, et al.
Cancers|April 27, 2024
The Vanishing Clinical Value of PD-L1 Status as a Predictive Biomarker in the First-Line Treatment of Urothelial Carcinoma of the BladderAlexander Tamalunas, Can Aydogdu, Lena M Unterrainer, et al.
IJU Case Reports|March 4, 2026
High-Grade Urothelial Carcinoma Arising From a Ureteral Diverticulum: A Rare Case ReportIason Papadopoulos, Stephan Ledderose, Benedikt Ebner, et al.
Clinical Genitourinary Cancer|June 3, 2026
Epidemiological Trends and Germline Variant Analysis of Young-Onset Bladder CancerGabriela M Diaz, Ilaha Isali, Laura Davis, et al.
Clinical Genitourinary Cancer|July 11, 2026
Baseline Sarcopenia is Associated With Overall Survival but Not Toxicity in Patients Receiving Enfortumab Vedotin Plus Pembrolizumab for Locally Advanced or Metastatic Urothelial CarcinomaCan Aydogdu, Simon Hahn, Benso John, et al.
World Journal of Urology|July 22, 2024
The impact of preoperative 5-alpha reductase inhibitors on functional outcomes and health-related quality of life following radical prostatectomy - A propensity score matched longitudinal studyThilo Westhofen, Kerstin Frank, Alexander Buchner, et al.
Cancers|June 27, 2024
Toxicity-Induced Discontinuation of Immune Checkpoint Inhibitors in Metastatic Urothelial Cancer: 6-Year Experience from a Specialized Uro-Oncology CenterSeverin Rodler, Can Aydogdu, Isabel Brinkmann, et al.
Urologic Oncology|October 8, 2025
Clinical and histological predictors of treatment outcomes in primary urethral carcinomaBetty Wang, Devika Nandwana, Laura E Davis, et al.
Cancers|March 28, 2026
Radiosurgery in Upper Tract Urothelial Carcinoma (UTUC)Michael Staehler, Iulia Blajan, Can Aydogdu, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Annals of Surgical Oncology|February 10, 2026
ASO Practice Guidelines Series: Surgical Management of Bladder Cancer RelapseCan Aydogdu, Sean T McSweeney, Vignesh T Packiam, et al.
Annals of Surgical Oncology|June 21, 2026
Preoperative Tumor-Informed ctDNA for Prediction of Nodal Metastases at Radical Cystectomy in Bladder CancerCan Aydogdu, Betty Wang, Sean McSweeney, et al.
Cancers|April 27, 2024
The Vanishing Clinical Value of PD-L1 Status as a Predictive Biomarker in the First-Line Treatment of Urothelial Carcinoma of the BladderAlexander Tamalunas, Can Aydogdu, Lena M Unterrainer, et al.
IJU Case Reports|March 4, 2026
High-Grade Urothelial Carcinoma Arising From a Ureteral Diverticulum: A Rare Case ReportIason Papadopoulos, Stephan Ledderose, Benedikt Ebner, et al.
Clinical Genitourinary Cancer|June 3, 2026
Epidemiological Trends and Germline Variant Analysis of Young-Onset Bladder CancerGabriela M Diaz, Ilaha Isali, Laura Davis, et al.
Clinical Genitourinary Cancer|July 11, 2026
Baseline Sarcopenia is Associated With Overall Survival but Not Toxicity in Patients Receiving Enfortumab Vedotin Plus Pembrolizumab for Locally Advanced or Metastatic Urothelial CarcinomaCan Aydogdu, Simon Hahn, Benso John, et al.
World Journal of Urology|July 22, 2024
The impact of preoperative 5-alpha reductase inhibitors on functional outcomes and health-related quality of life following radical prostatectomy - A propensity score matched longitudinal studyThilo Westhofen, Kerstin Frank, Alexander Buchner, et al.
Cancers|June 27, 2024
Toxicity-Induced Discontinuation of Immune Checkpoint Inhibitors in Metastatic Urothelial Cancer: 6-Year Experience from a Specialized Uro-Oncology CenterSeverin Rodler, Can Aydogdu, Isabel Brinkmann, et al.
Urologic Oncology|October 8, 2025
Clinical and histological predictors of treatment outcomes in primary urethral carcinomaBetty Wang, Devika Nandwana, Laura E Davis, et al.
Cancers|March 28, 2026
Radiosurgery in Upper Tract Urothelial Carcinoma (UTUC)Michael Staehler, Iulia Blajan, Can Aydogdu, et al.
Pageof 3